Publicaciones (32) Publicaciones de Marina Holgado Madruga

2023

  1. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  2. The Role of GAB1 in Cancer

    Cancers, Vol. 15, Núm. 16

2022

  1. Evolutionary Origins of Metabolic Reprogramming in Cancer

    International journal of molecular sciences, Vol. 23, Núm. 20

  2. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer

    Cancers, Vol. 14, Núm. 2

2014

  1. Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III

    Cancer Research, Vol. 74, Núm. 4, pp. 1238-1249

2010

  1. Development of an EGFRvIII specific recombinant antibody

    BMC Biotechnology, Vol. 10

2007

  1. The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation

    Journal of Biological Chemistry, Vol. 282, Núm. 11, pp. 7758-7769

2006

  1. c-Jun NH2-terminal kinase 2α2 promotes the tumorigenicity of human glioblastoma cells

    Cancer Research, Vol. 66, Núm. 20, pp. 10024-10031

  2. β1 integrins modulate cell adhesion by regulating insulin-like growth factor-II levels in the microenvironment

    Cancer Research, Vol. 66, Núm. 1, pp. 331-342

2005

  1. Host adaptor proteins Gab1 and CrkII promote InIB-dependent entry of Listeria monocytogenes

    Cellular Microbiology, Vol. 7, Núm. 3, pp. 443-457

  2. Identification of a specific domain responsible for JNK2α2 autophosphorylation

    Journal of Biological Chemistry, Vol. 280, Núm. 11, pp. 9913-9920

2004

  1. Role of the Grb2-Associated Binder 1/SHP-2 Interaction in Cell Growth and Transformation

    Cancer Research, Vol. 64, Núm. 6, pp. 2007-2015

2003

  1. Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors

    Cancer Research, Vol. 63, Núm. 1, pp. 250-255

  2. Gab1 is an integrator of cell death versus cell survival signals in oxidative stress

    Molecular and Cellular Biology, Vol. 23, Núm. 13, pp. 4471-4484

2002

  1. Elevated JNK activation contributes to the pathogenesis of human brain tumors

    Oncogene, Vol. 21, Núm. 33, pp. 5038-5046

  2. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors

    American Journal of Pathology, Vol. 160, Núm. 2, pp. 441-447

2001

  1. Grb-2-associated binder-1 is involved in insulin-induced egr-1 gene expression through its phosphatidylinositol 3′-kinase binding site

    DNA and Cell Biology, Vol. 20, Núm. 4, pp. 223-229

  2. The Gab1 Docking Protein Links the B Cell Antigen Receptor to the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway and to the SHP2 Tyrosine Phosphatase

    Journal of Biological Chemistry, Vol. 276, Núm. 15, pp. 12257-12265

2000

  1. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase

    Molecular and Cellular Biology, Vol. 20, Núm. 22, pp. 8513-8525

1999

  1. A conserved inositol phospholipid binding site within the pleckstrin homology domain of the Gab1 docking protein is required for epithelial morphogenesis

    Journal of Biological Chemistry, Vol. 274, Núm. 44, pp. 31719-31726